NEXENTIS TECHNOLOGIES INC. Cost of Revenue
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Cost of Revenue of $2.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-11-13
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for the quarter ending 2025-09-30 was $2.00K, a 97.40% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for the quarter ending 2025-06-30 was $2.00K, a 66.67% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for the quarter ending 2025-03-31 was $14.00K, a 50.00% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for the quarter ending 2024-12-31 was $55.00K.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for fiscal 2024 was $165.00K, a 200.00% increase from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for fiscal 2023 was $55.00K, a 65.26% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for fiscal 2022 was $158.31K, a 16.46% increase from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. cost of goods and services sold for fiscal 2021 was $135.94K, a 213.20% increase from fiscal 2020.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-13 | $4.00K derived: sum of 2 quarters · filed 2025-11-13 | $19.00K 10-Q · filed 2025-11-13 | $73.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-06-30 | $2.00K 10-Q · filed 2025-08-14 | $17.00K 10-Q · filed 2025-08-14 | $71.00K derived: sum of 3 quarters · filed 2025-08-14 | $148.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-03-31 | $14.00K 10-Q · filed 2025-05-15 | $69.00K derived: sum of 2 quarters · filed 2025-05-15 | $146.00K derived: sum of 3 quarters · filed 2025-11-13 | $152.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $132.00K derived: sum of 2 quarters · filed 2025-11-13 | $138.00K derived: sum of 3 quarters · filed 2025-11-13 | $165.00K 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $77.00K 10-Q · filed 2025-11-13 | $76.76K 10-Q · filed 2024-11-14 | $83.00K derived: sum of 2 quarters · filed 2025-11-13 | $110.00K 10-Q · filed 2025-11-13 | $110.52K 10-Q · filed 2024-11-14 | $95.77K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-14 | $5.78K 10-Q · filed 2024-08-14 | $34.00K 10-Q · filed 2025-08-14 | $33.76K 10-Q · filed 2024-08-14 | $18.77K derived: sum of 3 quarters · filed 2025-08-14 | $19.25K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-15 | $27.98K 10-Q · filed 2024-05-15 | $12.77K derived: sum of 2 quarters · filed 2025-05-15 | $13.25K derived: sum of 3 quarters · filed 2025-05-15 | $40.25K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$15.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$14.75K derived: sum of 2 quarters · filed 2025-03-31 | $12.25K derived: sum of 3 quarters · filed 2025-03-31 | $55.00K 10-K · filed 2025-03-31 | $55.18K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $476.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $27.48K derived: sum of 2 quarters · filed 2024-11-14 | $70.23K 10-Q · filed 2024-11-14 | $149.29K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $27.01K 10-Q · filed 2024-08-14 | $69.75K 10-Q · filed 2024-08-14 | $148.82K derived: sum of 3 quarters · filed 2024-08-14 | $173.22K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $42.75K 10-Q · filed 2024-05-15 | $121.81K derived: sum of 2 quarters · filed 2024-05-15 | $146.21K derived: sum of 3 quarters · filed 2024-05-15 | $159.21K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $79.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $103.47K derived: sum of 2 quarters · filed 2024-04-01 | $116.46K derived: sum of 3 quarters · filed 2024-04-01 | $158.31K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $24.40K 10-Q · filed 2023-11-14 | $37.40K derived: sum of 2 quarters · filed 2023-11-14 | $79.25K 10-Q · filed 2023-11-14 | $147.26K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $13.00K 10-Q · filed 2023-08-14 | $54.85K 10-Q · filed 2023-08-14 | $122.86K derived: sum of 3 quarters · filed 2023-08-14 | $176.50K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $41.85K 10-Q · filed 2023-05-15 | $109.86K derived: sum of 2 quarters · filed 2023-05-15 | $163.50K derived: sum of 3 quarters · filed 2023-05-15 | $174.86K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $68.01K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $121.66K derived: sum of 2 quarters · filed 2023-03-27 | $133.01K derived: sum of 3 quarters · filed 2023-03-27 | $135.94K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $53.64K 10-Q · filed 2022-11-14 | $65.00K derived: sum of 2 quarters · filed 2022-11-14 | $67.93K 10-Q · filed 2022-11-14 | $85.65K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $11.35K 10-Q · filed 2022-08-15 | $14.29K 10-Q · filed 2022-08-15 | $32.01K derived: sum of 3 quarters · filed 2022-08-15 | $32.01K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $2.93K 10-Q · filed 2022-05-16 | $20.65K derived: sum of 2 quarters · filed 2022-05-16 | $20.65K derived: sum of 3 quarters · filed 2022-05-16 | $25.56K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $17.72K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $17.72K derived: sum of 2 quarters · filed 2022-03-31 | $22.63K derived: sum of 3 quarters · filed 2022-03-31 | $43.41K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.91K derived: sum of 2 quarters · filed 2021-11-15 | $25.69K 10-Q · filed 2021-11-15 | $71.20K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $4.91K 10-Q · filed 2021-08-16 | $25.69K 10-Q · filed 2021-08-16 | $71.20K derived: sum of 3 quarters · filed 2021-08-16 | $71.20K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $20.77K 10-Q · filed 2021-05-18 | $66.29K derived: sum of 2 quarters · filed 2021-05-18 | $66.29K derived: sum of 3 quarters · filed 2021-05-18 | $131.28K derived: sum of 4 quarters · filed 2021-05-18 | ||||
| 2019-12-31 | $45.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $45.51K derived: sum of 2 quarters · filed 2021-03-29 | $110.51K derived: sum of 3 quarters · filed 2021-03-29 | $144.55K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $64.99K derived: sum of 2 quarters · filed 2020-11-12 | $99.03K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | $64.99K 10-Q · filed 2020-08-11 | $99.03K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | $34.04K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $111.09K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |